Breaking News, Collaborations & Alliances

JanOne Prepares for GMP Production

Bottling and labeling of clinical trial batches are expected to begin in early October led by Eurofins CDMO.

By: Contract Pharma

Contract Pharma Staff

JanOne Inc., a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has confirmed stability of its developmental batch run of JAN101. Working closely with selected bottling and labeling partner, Eurofins CDMO, the company is currently on track to initiate GMP production of JAN101 to support planned Phase 2b trials to treat peripheral artery disease (PAD). Required clinical batches of properly bottled and labeled p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters